Global Blood Therapeutics, Inc. announced the appointment of Scott Morrison, who brings 35 years of financial experience helping life sciences companies excel from start-up, through initial product launch, to global expansion. Mr. Morrison served as Ernst & Young's U.S. Life Sciences Leader since 2002 (retired December 2015).